MNKD vs VRTX: Which Stock is Better?

Side-by-side comparison of Mannkind Corp and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

MNKD

Mannkind Corp

$2.61

VRTX

Vertex Pharmaceuticals Inc

$456.69

Key Metrics Comparison

MetricMNKDVRTXWinner
Market Cap$804.14M$116.00BVRTX
P/E Ratio130.5030.12VRTX
EPS (TTM)$0.02$15.16VRTX
Revenue Growth0.5%0.1%MNKD
Gross Margin74.8%53.7%MNKD

Analyze MNKD

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MNKD or VRTX a better investment?

Comparing MNKD and VRTX: Mannkind Corp has a market cap of $804.14M while Vertex Pharmaceuticals Inc has $116.00B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MNKD and VRTX?

MNKD (Mannkind Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MNKD or VRTX?

Based on P/E ratios, VRTX trades at a lower multiple (30.1x vs 130.5x).

Which is growing faster: MNKD or VRTX?

MNKD has higher revenue growth at 0.5% vs 0.1% for VRTX.

Which company is more profitable: MNKD or VRTX?

Mannkind Corp (MNKD) has higher gross margins at 74.8% compared to 53.7% for VRTX.

Which is the larger company: MNKD or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $116.00B compared to $804.14M for MNKD.

Should I buy MNKD or VRTX in 2026?

Both MNKD and VRTX have investment merit. MNKD trades at $2.61 while VRTX trades at $456.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MNKD and VRTX stock?

Key differences: Market Cap ($804.14M vs $116.00B), P/E Ratio (130.5x vs 30.1x), Revenue Growth (0.5% vs 0.1%), Gross Margin (74.8% vs 53.7%).

Popular Stock Comparisons